Is It Time To Sell Unilever plc And Reckitt Benckiser Group Plc?

Unilever plc (LON: ULVR) and Reckitt Benckiser Group Plc (LON: RB) are highly valued, but are they too high?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If I asked you to pick the 10 safest stocks in the FTSE 100, I reckon there’s a good chance you’d include Unilever (LSE: ULVR) or Reckitt Benckiser (LSE: RB). And I think you’d be justified, as their worldwide reach of essential consumer products gives them sector-wise and geographic safety.

But with Unilever’s interim due on 23 July and the same from Reckitt Benckiser scheduled for 27 July, should we be looking to buy or sell now?

Modest growth

Both companies have modest but reasonably attractive EPS growth forecast, and both are off to a decent start this year. In the first quarter, Unilever saw underlying sales up 2.8%, with its all-important emerging markets business up 5.4% — but we did hear that competitive pressure is leading to lower pricing in the developed markets of the US and Europe. And currency movements were in its favour in the period.

Reckitt Benckiser also put in a good Q1, and though performance in emerging markets was mixed, sales in Europe and North America saw steady growth. Although overall reported sales growth only reached 1%, the firm reported like-for-like growth of 5%.

With the world economy still improving, we should expect a few steady years from both companies now, but the trouble is the share price is already ahead of it. At around the 2,850p mark, Unilever shares have gained 7% over the past 12 months. That’s beaten the index and isn’t bad for a safe stock, but we’re looking at a forward P/E of about 22 now. That’s around 50% ahead of the FTSE’s long-term average P/E, and though Unilever deserves a premium rating, it looks a little too high to me.

Even higher

Reckitt Benckiser is looking similar, with forecasts putting it on an even higher P/E of 25. We’ve seen a 20% hike in the Reckitt share price over the past year, to 5,890p, which is remarkable. But again, I think it’s taken the price up a bit too far now.

Historically, both companies’ shares have tended to trade in a P/E range that tops out in the low 20s, and that’s pretty much where they both are at the moment. Over the past year, the share prices have climbed ahead of earnings rises, which is what happens when future prospects are looking good. But over the next couple of years, I can see that reversing, with share prices not matching EPS gains and those P/E multiples coming down a little.

Weak dividends

And we don’t have much in the way of dividends to rely on, with Unilever expected to come close to the FTSE average yield of around 3%, and Reckitt only managing about 2%. Both companies might be worth adding as a safety bolster to your portfolio during a cyclical downturn, but at today’s prices I just think there are better safety bargains to be had with better dividend yields.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 UK shares I’m avoiding like the plague in today’s stock market

Stephen Wright is a big fan of UK shares. But both the FTSE 100 and the FTSE 250 contain companies…

Read more »

Investing Articles

Down 13.7% in 7 days, what’s going on with the Lloyds share price?

Our writer looks at recent movements in the Lloyds share price. And asks whether now could be a good time…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

The best investment quote of all time didn’t come from Warren Buffett!

Warren Buffett’s pithy quotes are both relevant and insightful. But the American billionaire didn’t come up with our writer’s favourite.

Read more »

Investing Articles

At 538p, is the Rolls-Royce share price really that expensive?

The Rolls-Royce share price has continued its incredible post-pandemic rally causing many to ask whether the stock’s overvalued. Our writer…

Read more »

Investing Articles

With yields over 8.8%, which of the FTSE 100’s top 5 passive income stocks do I think is the best?

These five passive income stocks are all yielding more than 8.8%. Our writer considers which of them (if any) would…

Read more »

Dividend Shares

Here’s a simple 5-stock dividend income portfolio with a 7.5% yield

With these five British dividend stocks, one could potentially generate income of around £750 per year from a £10,000 investment.

Read more »

Investing Articles

If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

Read more »

Investing Articles

Is Scancell the best penny stock for me to buy today?

The Scancell share price is on fire, jumping by 50% since July! But is this just the tip of the…

Read more »